Charles River Laboratories International Inc (NYSE:CRL)
$ 232.56 -0.26 (-0.11%) Market Cap: 11.98 Bil Enterprise Value: 14.74 Bil PE Ratio: 27.30 PB Ratio: 3.29 GF Score: 95/100

Charles River Laboratories International Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Dec 01, 2021 / 02:40PM GMT
Release Date Price: $361.15 (-1.29%)
Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst

Hi, everyone. Thanks so much for joining us this morning. For those of you who don't know me, I am Elizabeth Anderson, I'm the Healthcare Technology and Distribution Analyst here at Evercore. I'm very pleased to be joined this morning by Jim Foster, Chairman, President and CEO of Charles River; as well as Todd Spencer, Vice President of Investor Relations.

Questions & Answers

Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst

So maybe, Jim, just to start off with, do you want to maybe give us a little bit of a 30,000-foot overview? I'm sure most people on the call are familiar with Charles River, but just to sort of level set everybody before we jump in.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Sure. I'd be happy to. We are enjoying unprecedented demand pretty

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot